CDER lays out 2021 guidance agenda
The FDA’s Center for Drug Evaluation and Research (CDER) released a list of the new and revised draft guidances it plans to release in 2021 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
